Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Transpact Enterprises Limited is an innovative MedTech startup, providing therapeutic devices and rehabilitation services designed to assist specially-abled individuals.
The company is incubated by SINE, IIT Bombay, and is ISO 13485:2016 & ISO 9001:2015 certified, demonstrating its commitment to quality in medical devices.
Transpact's flagship products, such as the Vestibulator and Rehabsoft, utilize IoT technology for effective therapy and management solutions, enhancing patient care.
As the first startup listed on the BSE Startup Platform, Transpact shows strategic intent towards growth and public fundraising efforts.
The firm's focus on continuous technological advancement positions it well for addressing the needs of the MedTech industry and enhancing therapy delivery.
Healthcare Equipment & Supplies
Medical Equipment & Supplies
8 Cr
Low Risk
77.3
56.6
0.7
17.1
236.10
81.47
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
3
Neutral
5
Bullish
6
Bearish
17
Neutral
17
Bullish
12
Bearish
14
Neutral
12
Bullish
6
Bearish
3
Neutral
5
Bullish
6
Bearish
3
Neutral
5
Bullish
6
Bearish
14
Neutral
12
Bullish
6
Bearish
14
Neutral
12
Bullish
6
Bearish
14
Neutral
12
Bullish
6
Transpact Enterprises Ltd (TRANSPACT) is currently trading at 90.30 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Transpact Enterprises Limited is an innovative MedTech startup, providing therapeutic devices and rehabilitation services designed to assist specially-abled individuals. The company is incubated by SINE, IIT Bombay, and is ISO 13485:2016 & ISO 9001:2015 certified, demonstrating its commitment to quality in medical devices. Transpact's flagship products, such as the Vestibulator and Rehabsoft, utilize IoT technology for effective therapy and management solutions, enhancing patient care. As the first startup listed on the BSE Startup Platform, Transpact shows strategic intent towards growth and public fundraising efforts. The firm's focus on continuous technological advancement positions it well for addressing the needs of the MedTech industry and enhancing therapy delivery.
Over the past 52 weeks, Transpact Enterprises Ltd has traded between a low of ₹81.47 and a high of ₹236.10. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Transpact Enterprises Ltd has a market capitalization of approximately 7.73. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Transpact Enterprises Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 77.30 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 7.73 Cr, Transpact Enterprises Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Transpact Enterprises Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Transpact Enterprises Ltd is 77.30. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
72.40 | 63 Cr | 27.13 | 2.38 | 0.00 | 8.76 | 11.99 | 6.93 | ||
88.00 | 47 Cr | 6.58 | 1.24 | 0.00 | 17.67 | 20.31 | 11.72 | ||
132.80 | 44 Cr | 182.58 | 5.27 | 0.04 | 2.95 | 4.81 | 2.27 | ||
102.00 | 37 Cr | -26.02 | 1.39 | 0.00 | -7.72 | 2.14 | -1.79 | ||
64.36 | 32 Cr | 5.88 | 0.61 | 0.00 | 5.53 | 11.74 | 4.18 | ||
17.00 | 26 Cr | 7.54 | 0.74 | 4.12 | 8.47 | 11.15 | 7.01 | ||
90.30 | 8 Cr | 77.30 | 17.13 | 0.00 | 20.02 | 17.04 | 13.70 | ||
| Median: 7 Co. | — | 88.00 | 37 Cr | 7.54 | 1.39 | 0.00 | 8.47 | 11.74 | 6.93 |
AGM/EGM Notice
Transpact Enterprises Ltd: Consolidated Scrutinizer's Report for 13th AGM held via VC/OAVM on 2026-09-29 at 04:00 PM. Resolutions passed: approval of audited financials for FY2025-26 and re-appointment of Ms. Anamika Tiwari. Votes: 75,128 (100% of votes cast; 19.42% of shares).
AGM/EGM Notice
Transpact Enterprises held its 13th AGM on 2026-09-29 at 16:00 via VC/OAVM; financial statements and re-appointment of a director were considered. E-voting results to be declared within two working days.
